Rosenbauer's Order Book Is Full, but the Cash Is Flowing the Wrong Way
Published on 11/18/2026 at 03:21 | Editorial boerse-global.deRosenbauer has a backlog most industrial buyers would envy and a profit line that is finally moving in the right direction. What it does not have, at least through the first nine months of 2026, is cash coming in the door. That mismatch sat at the center of a fresh downgrade on Tuesday, when Baader Bank pulled its recommendation on the firefighting-vehicle maker down a notch.
Analyst Volker Bosse cut the stock from "Buy" to "Add" and trimmed his price target to 66.00 euros from 76.00 euros, citing third-quarter 2026 results that came in weaker than expected. He also lowered his forecasts for the full year and the years beyond, so the more cautious stance covers both the current period and the longer runway. The shares fell 5.8% to 52.40 euros following the reassessment.
A profit gain paired with a cash drain
The numbers Rosenbauer released on Friday tell a two-sided story. Revenue for the first nine months reached 978.6 million euros, with both sales and operating profit higher year on year. EBIT came in at 42.4 million euros, and net income for the period was 16.6 million euros.
Then there is the other column. Operating cash flow for the same stretch was negative 110.6 million euros. A company can post a positive operating result while still bleeding funds from its day-to-day business, and that is precisely the gap investors now have to weigh. A stronger profit alone does not settle the question of how much capital is tied up in getting the work done. A more reassuring scenario would have Rosenbauer hitting its earnings targets while reining in the outflow — making cash generation the real test of whether any improvement is worth paying for.
Should investors sell immediately? Or is it worth buying Rosenbauer?
Backlog offers support, not proof
At the end of September the order book stood at 2.45 billion euros, or 2,454.7 million euros in the company's own reporting. Management expects roughly 1.55 billion euros of revenue for the full year 2026 and around 90 million euros of EBIT.
The optimistic reading writes itself: a substantial backlog underpins future activity, and converting it should carry the business forward. The catch is that execution has to be profitable, not just busy. Orders are an argument for the outlook; they are not yet evidence of better cash conversion.
NuWays took the more upbeat path on Monday, reaffirming its buy rating and 71-euro target even while acknowledging the disappointing quarterly figures and the reduced annual guidance. The split between the two research houses lays out the decision facing investors — both reacted to the same soft results but drew different conclusions. The takeaway is to separate a broadly positive business outlook from the near-term reliability of earnings.
Rosenbauer at a turning point? This analysis reveals what investors need to know now.
What could keep a recovery in check
NuWays flagged the SAP S/4HANA rollout and the Middle East conflict as drags. Under the bear case, those factors make it harder to convert the backlog into revenue on schedule, which would leave a fat order book signaling potential without quickly delivering better profits or healthier cash flow.
Management's roughly 90 million euro EBIT target for 2026 is the next concrete checkpoint. As long as Rosenbauer can back that plan with operating performance, the constructive case holds together. If the cash outflow persists alongside it, the quality of the improvement is diminished. And if the cited pressures intensify, the execution story itself comes under strain. A convincing re-rating would need earnings progress and cash flow to move in the same direction — something the first nine months did not deliver.
Ad
Rosenbauer Stock: New Analysis - 18 November
Fresh Rosenbauer information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
